Themes · US
Ongoing theme
Bio & Pharma
An overview for this page is not available in English yet. The figures below are updated daily.
At a glance 2026-10-06 basis
Constituents21
Total market cap$4.15T
Avg. 1W-3.26%
Avg. 1M-3.35%
Avg. 3M+10.31%
Up over 1M33.3%
Median P/E32.5
Simple averages of constituents; not an index.
Constituents by market cap
| Company | Market cap | Day | 1W | 1M | 3M | P/E |
|---|---|---|---|---|---|---|
| 일라이 릴리 LLY | $1.02T | +1.26% | -2.29% | +0.71% | -4.80% | 38.1 |
| 존슨 앤드 존슨 JNJ | $609.5B | +0.73% | -4.78% | -7.43% | -3.27% | 29.0 |
| 애브비 ABBV | $469.6B | +0.35% | +1.29% | +3.99% | +5.52% | 74.7 |
| 머크 MRK | $344.3B | +1.72% | -4.92% | -5.58% | +12.66% | 108.5 |
| 써모 피셔 사이언티픽 TMO | $250.2B | -2.98% | -3.39% | +6.97% | +28.71% | 35.9 |
| 암젠 AMGN | $217.9B | -0.09% | -4.97% | -7.92% | +9.41% | 24.9 |
| 길리어드 사이언스 GILD | $179.3B | -0.28% | -4.66% | -4.48% | +6.19% | — |
| 화이자 PFE | $156.2B | +0.33% | -4.25% | -3.34% | +14.35% | 36.1 |
| 다나허 DHR | $155.5B | -2.53% | -4.64% | +3.83% | +13.02% | 38.8 |
| 인튜이티브 서지컬 ISRG | $143.6B | -0.42% | -1.80% | +10.38% | -2.49% | 45.8 |
| 버텍스 파머슈티컬 VRTX | $127.6B | -0.24% | -4.64% | -8.02% | +0.78% | 29.0 |
| Bristol-Myers Squibb Co. BMY | $120.1B | +1.33% | -5.20% | -10.82% | +3.56% | 12.9 |
| 메드트로닉 MDT | $112.5B | -1.00% | +0.00% | -7.52% | +6.19% | 21.5 |
| 모더나 MRNA | $81.1B | -7.75% | -7.86% | +28.79% | +154.01% | — |
| 리제네론 파머슈티컬스 REGN | $74.8B | +1.69% | -1.57% | -10.75% | +11.44% | 17.3 |
| Biogen Inc. Common Stock BIIB | $33.0B | -0.31% | -1.84% | +0.93% | +11.24% | 39.6 |
| ZOETIS INC. ZTS | $29.5B | -0.11% | +1.47% | -5.91% | -5.02% | 11.3 |
| Incyte Genomics Inc INCY | $23.1B | -1.23% | -8.50% | -11.06% | -3.86% | 14.3 |
| 바이오엔테크(ADR) BNTX | — | -1.96% | -2.88% | -7.74% | +2.35% | — |
| Direxion Daily S&P Biotech Bull 3X ETF LABU | — | -7.14% | -1.01% | -15.85% | -20.22% | — |
| 노보노디스크(ADR) NVO | — | -0.03% | -2.04% | -19.46% | -23.24% | — |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.